Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 0 | 3,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 3,000 | N/A | N/A | N/A |
| Operating Expenses | 37,827 | 29,216 | 22,847 | 20,089 | 19,159 |
| Operating Income | -37,827 | -26,216 | -22,847 | -20,089 | -16,659 |
| Other Income | 1,050 | 1,241 | 950 | 1,050 | 445 |
| Pre-tax Income | -36,777 | -24,975 | -21,897 | -19,039 | -16,214 |
| Net Income Continuous | -36,777 | -24,975 | -21,897 | -19,039 | -16,195 |
| Net Income | $-36,777 | $-24,975 | $-21,897 | $-19,039 | $-16,195 |
| EPS Basic Total Ops | -0.79 | -0.55 | -0.52 | -0.45 | -0.45 |
| EPS Basic Continuous Ops | -0.80 | -0.55 | -0.52 | -0.45 | -0.46 |
| EPS Diluted Total Ops | -0.79 | -0.55 | -0.52 | -0.45 | -0.45 |
| EPS Diluted Continuous Ops | -0.80 | -0.55 | -0.52 | -0.45 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.79 | -0.55 | -0.52 | -0.45 | -0.47 |
| EBITDA(a) | $-37,814 | $-25,673 | $-22,314 | $-19,559 | $-18,748 |